Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemia

  • S Hart, K C Goh, V Novotny-Diermayr, Y C Tan, B Madan, C Amalini, L C Ong, B Kheng, A Cheong, J Zhou, W J Chng, J M Wood
  • Blood Cancer Journal, November 2011, Springer Science + Business Media
  • DOI: 10.1038/bcj.2011.43

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr veronica diermayr